Supplementary Table S4 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma Chang Gon Kim , Min Hee Hong , Dahee Kim , Brian Hyohyoung Lee , Hyunwook Kim , Chan-Young Ock , Geoffrey Kelly , Yoon Ji Bang , Gamin Kim , Jung Eun Lee , Chaeyeon Kim , Se-Heon Kim , Hyun Jun Hong , Young Min Park , Nam Suk Sim , Heejung Park , Jin Woo Park , Chang Geol Lee , Kyung Hwan Kim , Goeun Park , Inkyung Jung , Dawoon Han , Jong Hoon Kim , Junha Cha , Insuk Lee , Mingu Kang , Heon Song , Chiyoon Oum , Seulki Kim , Sukjun Kim , Yoojoo Lim , Seunghee Kim-Schulze , Miriam Merad , Sun Och Yoon , Hyun Je Kim , Yoon Woo Koh , Hye Ryun Kim crossref（2024）
摘要
Reported trials on neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
更多 查看译文
AI 理解论文
溯源树
样例
